4//SEC Filing
Hunter Robyn 4
Accession 0001713932-26-000001
CIK 0000034956other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 7:53 PM ET
Size
9.1 KB
Accession
0001713932-26-000001
Insider Transaction Report
Form 4
Hunter Robyn
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-09+30,000→ 30,000 totalExercise: $13.30From: 2027-01-09Exp: 2036-01-09→ Common Stock (30,000 underlying)
Holdings
- 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 100,000
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying) - 80,000
Stock Option (right to buy)
Exercise: $5.75From: 2026-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying)
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact|2026-01-13
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001713932
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 7:53 PM ET
- Size
- 9.1 KB